Dr. Jennifer Taylor-Cousar is passionate about bringing attention to health inequities in cystic fibrosis. By partnering with the CF Foundation, other organizations, and the CF community, she believes we can work together to create equitable health outcomes for everyone with CF.
Site Search
Tomorrow's Leaders is a community of young professionals who come together to make a difference for those living with cystic fibrosis while growing their network, making personal connections, and developing professional skills.
National Teams raise awareness about cystic fibrosis, and raise funds to support the Foundation's mission to find a cure for CF.
The Cystic Fibrosis Foundation is requesting letters of intent for research projects that aim to identify biomarkers, improve knowledge of pathogenesis, and explore new approaches to treatment of chronic lung allograft dysfunction (CLAD).
We offer awards for cystic fibrosis research and for professional development and training. Below is a list of current and upcoming funding opportunities.
The Cystic Fibrosis Foundation is requesting letters of intent for research projects that aim to use available clinical trials in organ transplantation specimens and/or clinical data to improve knowledge of chronic lung allograft dysfunction pathogenesis and explore new approaches to detection, prevention, monitoring, or treatment of chronic lung allograft dysfunction.
When you are deciding whether to join a clinical trial, you should consider logistics.
With this approval, approximately 2,250 children in the U.S. will be eligible for Trikafta® (elexacaftor/tezacaftor/ivacaftor), including more than 900 who will have access to a CFTR modulator for the first time. The Cystic Fibrosis Foundation believes it is beneficial to start people with cystic fibrosis on modulators as early as possible to help prevent lung damage and the onset of complications.
The Cystic Fibrosis Foundation organized a multidisciplinary committee to develop a nutrition position paper to provide interim advice and considerations to the CF community around CF nutrition based on the rapidly changing nutrition landscape in CF.
Our understanding and treatment of cystic fibrosis has evolved significantly since Dr. Dorothy Andersen first discovered the disease in 1938, but harmful misconceptions around contagion, prevalence, and symptoms pervade. Here are key facts to know about this rare, genetic condition.